https://orcid.org/0000-0002-1673-1954
References
- Kallaste A, Kisand K, Aart A, et al. Antibody levels remain high to one-year’s follow-up after moderate and severe COVID-19, but not after mild cases. Infect Dis. 2021;1–11. DOI:https://doi.org/10.1080/23744235.2021.2018492
- Dan Jennifer M, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371(6529):eabf4063.
- Whitcombe AL, McGregor R, Craigie A, et al. Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand. Clin Trans Immunol. 2021;10(3):e1261.
- Yamayoshi S, Yasuhara A, Ito M, et al. Antibody titers against SARS-CoV-2 decline, but do not disappear for several months. EClinicalMedicine. 2021;32:100734.
- Tan Y, Liu F, Xu X, et al. Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection. Front Med. 2020;14(6):746–751.
- Vanshylla K, Di Cristanziano V, Kleipass F, et al. Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans. Cell Host Microbe. 2021;29(6):917–929.e4.
- Wagner A, Guzek A, Ruff J, et al. Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults. Commun Med. 2021;1(1):13.
- Zhu L, Xu X, Zhu B, et al. Kinetics of SARS-CoV-2 specific and neutralizing antibodies over seven months after symptom onset in COVID-19 patients. Microbiol Spectr. 2021;9(2):e0059021–e0059021.
- Long QX, Liu BZ, Deng HJ, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26(6):845–848.
- Wei J, Matthews PC, Stoesser N, et al. Anti-spike antibody response to natural SARS-CoV-2 infection in the general population. Nat Commun. 2021;12(1):6250.